| Market Capitalization (Millions $) |
4,683 |
| Shares
Outstanding (Millions) |
102 |
| Employees |
3,700 |
| Revenues (TTM) (Millions $) |
1,097 |
| Net Income (TTM) (Millions $) |
204 |
| Cash Flow (TTM) (Millions $) |
156 |
| Capital Exp. (TTM) (Millions $) |
64 |
Globus Medical Inc
Globus Medical Inc. is a medical device company that develops, manufactures, and markets musculoskeletal implants and surgical products. The company's products are designed for patients suffering from conditions such as spinal disorders, trauma, and joint instability. Globus Medical's product portfolio includes devices for spinal fusion, motion preservation, vertebral compression fracture treatment, and orthopedic trauma.
The company was founded in 2003 by David Paul, a former lawyer who had also worked in the medical device industry. He partnered with his brother, a surgeon, and together they set out to create a company that would revolutionize the field of musculoskeletal care. Since then, the company has grown rapidly, becoming one of the most successful medical device companies in the world.
Globus Medical operates in over 25 countries worldwide, with a strong presence in the United States, Europe, and Asia. The company's headquarters is located in Audubon, Pennsylvania, where it employs approximately 2,500 people. The company also has several manufacturing facilities located in the United States and Europe.
Globus Medical's product portfolio includes more than 160 products across four categories: spine, trauma, Orthobiologics, and joint replacement. The company's spine products comprise of implants and devices that treat conditions such as spinal stenosis, herniated discs, and scoliosis. The company's trauma products include systems that provide treatment for fractures and other injuries. The company's Orthobiologics segment covers various solutions for bone and soft tissue healing. The joint replacement segment provides implants for various joints, including the hip, knee, shoulder, and elbow.
Globus Medical's dedication to research and development has been one of the driving forces behind its success. The company invests heavily in developing innovative products and technologies that improve patient outcomes and reduce healthcare costs. The company has a team of more than 300 engineers and researchers who work to create new products and improve existing ones. Moreover, the company has over 470 patents to its name, reflecting the organization's focus on innovation.
Since going public in 2012, Globus Medical has experienced tremendous growth. The company's revenue has increased from $419 million in 2012 to a whooping $857 million in 2019. The company's commitment to delivering high-quality products and services has earned it numerous industry accolades, including being named one of the fastest-growing companies in the United States in recent times.
In conclusion, Globus Medical Inc is a leading medical device company that has revolutionized the field of musculoskeletal care. The company's strong focus on research and development, combined with its commitment to improving patient outcomes have made it one of the most successful and recognized players in the medical device industry. With its portfolio of innovative products, extensive global reach, and dedicated workforce, the company is poised to continue its growth and dominance in the coming years.
Company Address: 2560 General Armistead Avenue Audubon 19403 PA
Company Phone Number: 930-1800 Stock Exchange / Ticker: NYSE GMED
| GMED is expected to report next financial results on February 20, 2024. |
|
|
